Prof. Huaping Xu served for Executive Editor of ACS Applied Materials & Interfaces

ACS AMI
Prof. Huaping Xu served for Executive Editor of ACS Applied Materials & Interfaces since June 2024. ACS Applied Materials & Interfaces serves the interdisciplinary community of chemists, engineers, physicists and biologists focusing on how newly-discovered materials and interfacial processes can be developed and used for specific applications. The editors are proud of the rapid growth of the journal since its inception in 2009, both in terms of the number of published articles and the impact of the research reported in those articles. ACS AMI is also truly international, with the majo...
More

Dynamic covalent bond-based materials: From construction to biomedical applications

xianyubanruo
Banruo Xianyu and Huaping Xu* Supramolecular Materials; 2024, 3, 100070 Dynamic covalent bonds (DCBs) have received significant interest due to their unique reversibility and stimuli-responsiveness. The introduction of DCBs provides materials with self-healing and controllable load and release properties, which result in the emergence of widespread applications in biomedical disciplines. In this minireview, we first introduce the chemistry nature and reaction characteristics of different types of DCBs followed by discussing the design strategies of DCB materials. Finally, we summarize the la...
More

Selenium-Containing Dynamic Materials: Structure Programming through Selective Dissipation

yizhengtan
Yizheng Tan and Huaping Xu* Acc. Mater. Res.; 2024, 5, 739 The success of living systems lies in using mild conditions to construct diverse structures by reducing energy barriers that need to be overcome. However, the most powerful processing methods developed by humans, such as integrated die casting and additive manufacturing, are either energy-consuming or time-consuming. Hence, it is very attractive and environmentally friendly to use simple, pre-built, programmable components and transform them into structures with various functions by using mild processing methods. Dynamic covalent b...
More

Modular 3D shape programming method for multiple substrates

Yizheng Tan, Yiheng Dai, Peng Zhao, Cheng Liu*, Huaping Xu* Matter; 2024, 7, 1117. Modular strategy is specialized in universality, compatibility, and simplicity. Although previous strategies still rely on highly customized processes, our research uses modular design to improve the simplicity and compatibility of shape programming. The module we used has a predefined hexagonal shape, which is mass-producible and can be transferred to a 2D substrate to produce controllable deformation in situ through nonpattern stimuli. This process can be finished in seconds due to the great responsiveness...
More

Polyurethane with β-Selenocarbonyl Structure Enabling the Combination of Plastic Degradation and Waste Upcycling

Chaowei He, Cheng Liu, Shuojiong Pan, Yizheng Tan, Jun Guan*, Huaping Xu* Angew. Chem. Int. Ed.; 2024, 68, e202317558. Degradable polymers offer a promising solution to mitigate global plastic pollution, but the degraded products often suffer from diminished value. Upcycling is a more sustainable approach to upgrade polymer waste into value-added products. Herein, we report a β-selenocarbonyl-containing polyurethane (SePU), which can be directly degraded under mild conditions into valuable selenium fertilizers for selenium-rich vegetable cultivation globally, enabling both plastic degradatio...
More

Selenium-Containing Nanocomplexes Achieve Dual Immune Checkpoint Blockade for NK Cell Reinvigoration

Banruo Xianyu, Shuojiong Pan, Shiqian Gao, Huaping Xu*, Tianyu Li* Small, 2023, 2306225. The blockade of immune checkpoints has emerged as a promising strategy for cancer immunotherapy. However, most of the current approaches focus on T cells, leaving natural killer (NK) cell-mediated therapeutic strategies rarely explored. Here, a selenium-containing nanocomplex is developed that acts as a dual immune checkpoint inhibitor to reinvigorate NK cell-based cancer immunotherapy. The Se nanocomplex can deliver and release siRNA that targets programmed death ligand-1 (PD-L1) in tumor cells, there...
More